Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam in Pediatric Cardiac Surgery
NCT00982527Phase 3Completed
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute kidney injury (AKI) comparing Placebo with Fenoldopam (2 arms). Primary endpoint: Neutrophil Gelatinase-Associated Lipocalin. Started Sep 2009; status: completed.
02
Drugs
fenoldopam
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00982527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982527.